Grassley: FDA officials OK'd surveillance on groups of doctors wary of medical device safety

NewsGuard 100/100 Score

The Washington Post: FDA Lawyers Authorized Spying On Agency's Employees, Senator Says
Congressional investigators said Monday that the chief counsel's office at the Food and Drug Administration authorized wide-ranging surveillance of a group of the agency's scientists, the first indication that the effort was sanctioned at the highest levels. In a letter to the FDA, Sen. Charles E. Grassley (R-Iowa) said that his staff had learned that the spying was "explicitly authorized, in writing" by the agency's top legal office. … The disclosure marked the latest turn in an investigation of the FDA's past efforts to monitor the communications of a group of its doctors who were expressing concerns about the safety of medical devices (Nakashima and Rein, 7/16).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials